Drugs like Ozempic and Wegovy lower risks for 42 conditions but increase risks for 19 others
New Scientist - 20-Jan-2025Approved uses are beneficial, but risks for off-label uses remain uncertain
Join the club for FREE to access the whole archive and other member benefits.
Private multidisciplinary research university.
Washington University in St. Louis, a medium-sized, independent university, is dedicated to challenging its faculty and students alike to seek new knowledge and greater understanding of an ever-changing, multicultural world. The university has played an integral role in the history and continuing growth of St. Louis and benefits in turn from the wide array of social, cultural and recreational opportunities offered by the metropolitan area to its more than 2.8 million residents.
Visit website: https://wustl.edu/
washington-university-in-st-louis
Details last updated 07-Dec-2019
Approved uses are beneficial, but risks for off-label uses remain uncertain
12 months of IF results in a range of biomarker improvements, but no significant reduction in inflammatory markers
Reduced inflammation & bone damage in mice; relieves patients from their regular use of injections
Engineered cells produce anti-inflammatory drug that helps reduce stress-related cartilage damage
This new approach doubled muscle mass in mice, reduced its fat
Professor of Neurology and scientific director of the Hope Center for Neurological Disorders at Washington University
Assistant Professor of Biochemistry and Molecular Biophysics at Washington University
Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University in St. Louis
Washington University School of Medicine Professor, Diabetes Researcher, Stem Cell Biologist
Assistant Professor of Radiology, Neurology and Neuroscience at Washington University in St. Louis.